Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
PRME
$3.90
-0.51%
PRME
· Prime Medicine, Inc.
$3.90
-0.02 (-0.51%)
At close · Oct 21
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result, we concluded that substantial doubt exists about our ability to continue as a going concern for 12 months from the date these condensed consolidated financial statements are issued.”View the 10-Q filed Aug 6, 2026
Market Cap
$711.00M
Shares
181.38M
Volume · Oct 20
3.69M
Avg daily vol (3M)
3.49M
All webcasts
Earnings call · FY2025 Q3
Prime Medicine, Inc. (PRME) Q3 2025 Earnings Call
Revenue
$1.23M
+486.1% YoY
Diluted EPS
-$0.32
Net income
-$50.58M
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Nov 7, 2025 · complete as-filed document
SEC periodic report
10-Q report
Filed Nov 7, 2025 · complete as-filed document